Strategy

Bionamics identifies and evaluates projects from academia, biotech- and pharmaceutical companies.

Bionamics focuses on the acquisition or licensing of pre-clinical projects with a transparent pathophysiological background including an identified target and the respective drug candidates.

Bionamics will manage the acquired project in order to execute its efficient development or replacement program and commercialisation process.

Bionamics´s strategy is to create added value for its investors and inventors.

Bionamics utilizes the proven expertise of the inventors in combination with the professionalism and reliability of selected external CROs and CMOs, in order to ensure an efficient project progress.